Found: 12
Select item for more details and to access through your institution.
ABCB1 haplotype and OPRM1 118A . G genotype interaction in methadone maintenance treatment pharmacogenetics.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2012, v. 5, p. 53, doi. 10.2147/PGPM.S29272
- By:
- Publication type:
- Article
Pharmacogenetics of Opioids.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 3, p. 429, doi. 10.1038/sj.clpt.6100095
- By:
- Publication type:
- Article
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 6, p. 682, doi. 10.1016/j.clpt.2006.09.011
- By:
- Publication type:
- Article
Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model.
- Published in:
- Journal of Neurochemistry, 2012, v. 122, n. 5, p. 976, doi. 10.1111/j.1471-4159.2012.07833.x
- By:
- Publication type:
- Article
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney Transplantation.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 3, p. 320, doi. 10.1111/bcpt.13016
- By:
- Publication type:
- Article
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2019.01686
- By:
- Publication type:
- Article
Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3901, doi. 10.1111/bcp.14806
- By:
- Publication type:
- Article
High and variable population prevalence of HLA‐B*56:02 in indigenous Australians and relation to phenytoin‐associated drug reaction with eosinophilia and systemic symptoms.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 9, p. 2163, doi. 10.1111/bcp.14025
- By:
- Publication type:
- Article
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 720, doi. 10.1002/cpt.2640
- By:
- Publication type:
- Article
New pharmacological perspectives and therapeutic options for opioids: Differences matter.
- Published in:
- Anaesthesia & Intensive Care, 2022, v. 50, n. 1/2, p. 127, doi. 10.1177/0310057X211063891
- By:
- Publication type:
- Article
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137179
- By:
- Publication type:
- Article